Page 2087 - Hematology_ Basic Principles and Practice ( PDFDrive )

1856 Part XII Hemostasis and Thrombosis

Kerbel R, Folkman J: Clinical translation of angiogenesis inhibitors. Nat Rev Rafii S, Lyden D, Benezra R, et al: Vascular and haematopoietic stem cells:
Cancer 2:727, 2002. Novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2:826, 2002.
Lapidot T, Dar A, Kollet O: How do stem cells find their way home? Blood Rak J, Milsom C, May L, et al: Tissue factor in cancer and angiogenesis: The
106:1901, 2005. molecular link between genetic tumor progression, tumor neovasculariza-
Luster AD, Alon R, von Andrian UH: Immune cell migration in inflam- tion, and cancer coagulopathy. Semin Thromb Hemost 32:54, 2006.
mation: present and future therapeutic targets. Nat Immunol 6:1182, Schofield L, Grau GE: Immunological processes in malaria pathogenesis. Nat
2005. Rev Immunol 5:722, 2005.
Miyasaka M, Tanaka T: Lymphocyte trafficking across high endothelial Shih T, Lindley C: Bevacizumab: an angiogenesis inhibitor for the treatment
venules: dogmas and enigmas. Nat Rev Immunol 4:360, 2004. of solid malignancies. Clin Ther 28:1779, 2006.
Mehta D, Malik AB: Signaling mechanisms regulating endothelial perme- Yin T, Li L: The stem cell niches in bone. J Clin Invest 116:1195, 2006.
ability. Physiol Rev 86:279, 2006. Yonekawa K, Harlan JM: Targeting leukocyte integrins in human diseases. J
Minami T, Aird WC: Endothelial cell gene regulation. Trends Cardiovasc Leukoc Biol 77:129, 2005.
Med 15:174, 2005.
Petri B, Bixel MG: Molecular events during leukocyte diapedesis. FEBS J
273:4399, 2006. REFERENCES
Pober JS, Min W: Endothelial cell dysfunction, injury and death. Handb Exp
Pharmacol 135:2006. For the complete list of references, log on to www.expertconsult.com.